Viewing Study NCT01457495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-01-16 @ 5:39 PM
Study NCT ID: NCT01457495
Status: COMPLETED
Last Update Posted: 2017-06-16
First Post: 2011-10-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B View
None Diphtheria View
None Haemophilus Influenzae Type b (Hib) View
None Poliomyelitis View
None Pertussis View
None Tetanus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Infants View
None combined vaccine View
None DTPa-HBV-IPV/Hib View
None DTPa-IPV/Hib View
None safety View
None Immunogenicity View
None HBV View